The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
31 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $16,139,284 in first-year total cost, median $482,575.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-E (56)]13
- Special Emphasis Panel[ZRG1 AARR-P (56)]5
- Special Emphasis Panel[ZRG1-AARR-E(56)R]4
- Special Emphasis Panel[ZRG1 AARR-K (57)]3
- Special Emphasis Panel[ZRG1-AARR-K(57)R]3
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY2
- SEATTLE CHILDREN'S HOSPITAL2
- UNIVERSITY OF ALABAMA AT BIRMINGHAM2
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Defining HIV reservoirs that rebound following suspension of ART1R01AI134419-01 | FRENKEL, LISA MVANDEKERCKHOVE, LINOS | SEATTLE CHILDREN'S HOSPITAL, WA | $829,247 | ZRG1 |
| 2017 | Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells1R01AI122842-01A1 | KUTSCH, OLAF | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $662,624 | ZRG1 |
| 2017 | Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir1R01AI134328-01 | HO, DAVID D | AARON DIAMOND AIDS RESEARCH CENTER, NY | $595,153 | ZRG1 |
| 2017 | A New Approach to Reactivating HIV from Latency1R01AI134406-01 | HAASE, ASHLEY T. | UNIVERSITY OF MINNESOTA, MN | $527,939 | ZRG1 |
| 2017 | CTL-Mediated Elimination of Replication Competent vs. Defective HIV Proviruses from Natural Latent Reservoirs: Roles of Antigen Specificity and Functional Characteristics1R01AI131798-01A1 | JONES, R. BRAD | GEORGE WASHINGTON UNIVERSITY, DC | $398,750 | ZRG1 |
| 2017 | Understanding HIV latency reversal and clearance of infected cells in vivo1R01AI132128-01 | WONG, JOSEPH KYUKL, STEVEN A | NORTHERN CALIFORNIA INSTITUTE/RES/EDU, CA | $383,250 | ZRG1 |
| 2016 | Development of SMAC mimetics as latency-reversing agents1R01AI124843-01 | CHANDA, SUMIT KPLANELLES, VICENTE | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $710,559 | ZRG1 |
| 2016 | HIV latency reversal through novel, potent PKC modulators1R01AI124743-01 | WENDER, PAUL ANTHONYZACK, JEROME A. | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $645,378 | ZRG1 |
| 2016 | TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs1R01AI127089-01 | WHITNEY, JAMES BURTON | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $585,879 | ZRG1 |
| 2016 | HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence1R01AI127346-01 | SU, LISHANXIONG, YUE | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $532,000 | ZRG1 |
| 2016 | Immune responses to HSV-2 recurrence replenish HIV tissue reservoirs during ART1R01AI124770-01A1 | BULL, MARTA | SEATTLE CHILDREN'S HOSPITAL, WA | $482,575 | ZRG1 |
| 2016 | Do HIV-infected Alveolar Macrophages represent a cART-resistant Reservoir?1R56AI122811-01 | RUSSELL, DAVID G | CORNELL UNIVERSITY, NY | $462,345 | ZRG1 |
| 2016 | Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells1R56AI122842-01 | KUTSCH, OLAF | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $455,344 | ZRG1 |
| 2016 | Targeting HIV persistence in CD4+ T memory stem cells1R56AI125173-01 | SIMON, VIVIANA A | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $423,750 | ZRG1 |
| 2016 | Fate of Invisible U/A Base Pairs Within HIV DNA in Myeloid Phagocytic Cells1R01AI124777-01 | STIVERS, JAMES T. | JOHNS HOPKINS UNIVERSITY, MD | $401,521 | ZRG1 |
| 2016 | Single Cell Characterization of Latent HIV-1 Reservoirs1R01AI122862-01A1 | DEMIRCI, UTKANHENRICH, TIMOTHY JENSEN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $382,769 | ZRG1 |
| 2016 | Targeting the host kinase DYRK1A to optimize reversal of HIV-1 latency in CD4 T cells1R56AI122813-01A1 | WALLET, MARK A | UNIVERSITY OF FLORIDA, FL | $375,596 | ZRG1 |
| 2016 | Developing Pathogen Recognition Receptor Agonists as Latency Reversing Agents1R01AI124722-01A1 | BOSQUE, ALBERTO | UNIVERSITY OF UTAH, UT | $74,050 | ZRG1 |
| 2015 | Immune based interventions for HIV eradication1R01AI116379-01A1 | PAIARDINI, MIRKO | EMORY UNIVERSITY, GA | $890,819 | ZRG1 |
| 2015 | Timing of ART and homeostasis of the persistent HIV reservoir in the adult1R01AI116368-01A1 | MCCUNE, JOSEPH M | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $765,501 | AIP |
| 2015 | Identification of Signals Required for the Establishment of HIV Infection and Latency1R56AI118682-01 | HENDERSON, ANDREW J | BOSTON MEDICAL CENTER, MA | $761,143 | ZRG1 |
| 2015 | Kupffer Cells and HIV-1 Persistence1R56AI118445-01A1 | BALAGOPAL, ASHWIN | JOHNS HOPKINS UNIVERSITY, MD | $744,943 | ZRG1 |
| 2015 | Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node1R01AI118694-01A1 | BETTS, MICHAEL R | UNIVERSITY OF PENNSYLVANIA, PA | $704,645 | AIP |
| 2015 | Reservoir depletion and anti-retroviral therapy for infant functional cure1R01AI118451-01 | HARTIGAN-O'CONNOR, DENNIS J. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $669,787 | ZRG1 |
| 2015 | Cholesterol-dependent control of HIV progression by antigen presenting cells1R01AI118403-01 | RAPPOCCIOLO, GIOVANNARINALDO, CHARLES R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $548,198 | ZRG1 |
| 2015 | Towards HIV eradication using a novel Tat inhibitor1R01AI118432-01A1 | VALENTE, SUSANA T | SCRIPPS FLORIDA, FL | $473,960 | ZRG1 |
| 2015 | The contribution of unintegrated HIV-1 to latency and to models of latency1R56AI118453-01A1 | LEVY, DAVID N | NEW YORK UNIVERSITY, NY | $396,250 | ZRG1 |
| 2015 | Animal Model for Testing SIV Latency Reversal Strategies1R01AI119346-01A1 | APETREI, CRISTIAN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $390,499 | ZRG1 |
| 2015 | Molecular Mechanisms of HIV Innate Immune Evasion1R56AI120954-01 | COLLINS, KATHLEEN L. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $334,300 | ZRG1 |
| 2015 | Effects of Cell-Intrinsic Immunity on Establishment and Reversal of HIV Latency1R01GM117901-01 | PILLAI, SATISH KUMAR | VITALANT, AZ | $330,552 | ZRG1 |
| 2015 | Genome Editing by Homologous Recombination to Create HIV Resistant Immune System1R01AI120766-01 | PORTEUS, MATTHEW H | STANFORD UNIVERSITY, CA | $199,958 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.